NEW LOWER PRICES - ACT FAST
Medicine (MD/DO)
/
Courses
/
Immunology & Oncology
/
Immunosuppressants & Antineoplastic Agents
/
Rituximab

Master Rituximab with Picmonic for Medicine

With Picmonic, facts become pictures. We've taken what the science shows - image mnemonics work - but we've boosted the effectiveness by building and associating memorable characters, interesting audio stories, and built-in quizzing.

DOWNLOAD PDF
Rituximab

Recommended Picmonics

picmonic thumbnail
Chronic Lymphocytic Leukemia (CLL)
picmonic thumbnail
Cold Agglutinin Autoimmune Hemolytic Anemia (C-AIHA)
picmonic thumbnail
Prednisone (Glucocorticoids)
picmonic thumbnail
Cyclosporine (Sandimmune) Overview
picmonic thumbnail
Cyclosporine (Sandimmune) Side Effects

Rituximab

Red-tux-mob
Picmonic
Rituximab is a monoclonal antibody medication targeting CD20, a protein expressed on B-cells. For this reason, this medication is effective in treating disorders of B-cell malignancy, dysfunction or excess. Side effects of using this medication include infusion reactions at the site of IV administration, and the development of skin and oral reactions. Rituximab is associated with infusion reactions, reactivation of hepatitis B virus, and the development of progressive multifocal leukoencephalopathy.
11 KEY FACTS
INDICATIONS
Chronic Lymphocytic Leukemia (CLL)
CaLL me Crone

Rituximab destroys both normal and malignant B cells that have CD20 on their surfaces, and can be used for lymphomas and leukemias. Rituximab is indicated in treating previously untreated and previously treated CD20-positive CLL.

Non-Hodgkin Lymphoma
Nun-hog-king with Lime-foam

Rituximab destroys both normal and malignant B cells that express CD20 on their surfaces and can be used for the treatment of lymphomas and leukemias. This medication is indicated for treating previously untreated, stable, and refractory cases of non-Hodgkin lymphoma (NHL)

Rheumatoid Arthritis
Roman King-Arthur

Rituximab, when used in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more TNF-inhibitor therapies.

Microscopic Polyangiitis (MPA)
Microscope Polly-angel

Rituximab is combined with glucocorticoids to treat microscopic polyangiitis (MPA), a small vessel vasculitis.

Granulomatosis with Polyangiitis (Formerly Wegener's)
Granny-llama with Polly-angel

Rituximab is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (formerly Wegener's Granulomatosis), and is used in combination with glucocorticoids.

MECHANISM
Monoclonal Antibody Against CD20
Monocle Ant-tie-body with CD (20) Dollar-bill

Rituximab is a monoclonal antibody targeting CD20. This means that it is derived from identical immune cells, all clones of a unique parent cell, producing a specific antibody against the CD20 protein expressed on B-cells.

Found on B Cell Neoplasms
Basket-balls

CD20 is widely expressed on B-cells, and Rituximab binds as an antibody to these CD20 proteins. Once bound, a conformational change occurs, making these "tagged" B-cells easily identifiable by natural killer (NK) cells.

SIDE EFFECTS
Infusion Reactions
In-fused-IV Reaction

During IV administration of rituximab or within 24 hours, patients may develop infusion reactions. These reactions are characterized by hives, rash, itching, facial or oral swelling, sudden cough, shortness of breath, difficulty breathing, and chest pain.

Skin and Mouth Reactions
Skin-suit and Mouth Reactions

During IV administration of rituximab or within 24 hours, patients may develop infusion reactions. These reactions are characterized by hives, rash, itching, facial or oral swelling, sudden cough, shortness of breath, difficulty breathing, and chest pain.

Reactivation of Hepatitis B Virus (HBV)
Happy-tie-liver Bee

Patients who have had hepatitis B or are carriers of hepatitis B virus may develop a reactivation infection from rituximab. Patients should not take this medication if they have active HBV liver disease, as reactivation may lead to worsening liver disease or death. Patients taking this drug should have diagnostic blood work done prior to administration, and should be followed for several months after rituximab is initiated by their provider.

Progressive Multifocal Leukoencephalopathy (PML)
PML-brain

There is also an association between rituximab administration and the development of progressive multifocal leukoencephalopathy (PML). This is a rare, rapidly progressive, and usually fatal condition caused by the reactivation of the JC virus. Symptoms include focal neurological deficits, blurred or lost vision, and seizures.

DOWNLOAD PDF

Take the Rituximab Quiz

Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.

It's worth every penny

Our Story Mnemonics Increase Mastery and Retention

Memorize facts with phonetic mnemonics

Unforgettable characters with concise but impactful videos (2-4 min each)

Memorize facts with phonetic mnemonics

Ace Your Medicine (MD/DO) Classes & Exams with Picmonic:

Over 1,870,000 students use Picmonic’s picture mnemonics to improve knowledge, retention, and exam performance.

Choose the #1 Medicine (MD/DO) student study app.

Picmonic for Medicine (MD/DO) covers information that is relevant to your entire Medicine (MD/DO) education. Whether you’re studying for your classes or getting ready to conquer the USMLE Step 1, USMLE Step 2 CK, COMLEX Level 1, or COMLEX Level 2, we’re here to help.

Works better than traditional Medicine (MD/DO) flashcards.

Research shows that students who use Picmonic see a 331% improvement in memory retention and a 50% improvement in test scores.